Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 35 Glioblastoma 24 Carcinoma, Non-Small-Cell Lung 21 Ovarian Neoplasms 14 Carcinoma, Hepatocellular 14 Brain Neoplasms 14 Carcinoma, Renal Cell 13 Pancreatic Neoplasms 12 Neoplasms 10 Neoplasm Metastasis 10 Glioma 10 Breast Neoplasms 10 Colonic Neoplasms 8 Astrocytoma 8 Melanoma 7 Uterine Cervical Neoplasms 6 Rectal Neoplasms 6 Liver Neoplasms 6 Gliosarcoma 6 Endometrial Neoplasms 6 Stomach Neoplasms 5 Lung Neoplasms 5 Fallopian Tube Neoplasms 5 Colorectal Cancer Metastatic 5 Advanced Solid Tumors 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Oligodendroglioma 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3

Interventions

Temozolomide 6 Radiotherapy 4 Irinotecan 3 lutetium Lu 177 dotatate 2 Nivolumab 2 Carboplatin 2 sonidegib 1 sodium thiosulfate 1 silmitasertib 1 poly ICLC 1 plerixafor 1 olaparib 1 gallium Ga 68 dotatate 1 etoposide phosphate 1 entrectinib 1 dinutuximab 1 bempegaldesleukin 1 adavosertib 1 abemaciclib 1 Vincristine 1 Vascular Endothelial Growth Factor A 1 Vaccines 1 Triiodothyronine 1 TPI-287 1 Surgical Procedures, Operative 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Microarray Analysis 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Medulloblastoma × Bevacizumab × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡